<- Go home

Added to YB: 2025-02-17

Pitch date: 2025-02-06

RVTY [bullish]

Revvity, Inc.

-15.39%

current return

Author Info

No bio for this author

Company Info

Revvity, Inc. provides health sciences solutions, technologies, and services. The company provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and DNA sequencing services; and instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.

Market Cap

$10.5B

Pitch Price

$118.78

Price Target

N/A

Dividend

0.30%

EV/EBITDA

15.05

P/E

47.57

EV/Sales

4.60

Sector

Life Sciences Tools and Services

Category

turnaround

Show full summary:
Bretton Fund Portfolio Holding: Revvity, Inc.

RVTY: Ex-PerkinElmer pivots post-Covid. Now focused on reagents (75k products) & immunodiagnostics. Smaller units: lab software & newborn screening. Healthcare industry hangover after Covid windfall. 2.4% gain last year, trades at 23x earnings. Simplified portfolio after acquisitions & disposals.

Read full article (1 min)